Effective contact tracing for COVID-19: A systematic review
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.07.23.20160234: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Search strategy: MEDLINE (1946 - 2020 July 8), Embase (1974 - 2020 July 10), Global Health (1973 - 2020 Week 26), and All EBM Reviews (2005 - 2020 July 10) were searched using the terms “COVID-19” OR “coronavirus disease 2019” OR “SARS-CoV-2” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-NCoV” OR “2019 novel coronavirus” AND “contact tracing” OR“contact-tracing” OR “tracing contact*” OR “contact follow-up” OR “case detection*” OR “contact investigation*” OR … SciScore for 10.1101/2020.07.23.20160234: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Search strategy: MEDLINE (1946 - 2020 July 8), Embase (1974 - 2020 July 10), Global Health (1973 - 2020 Week 26), and All EBM Reviews (2005 - 2020 July 10) were searched using the terms “COVID-19” OR “coronavirus disease 2019” OR “SARS-CoV-2” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-NCoV” OR “2019 novel coronavirus” AND “contact tracing” OR“contact-tracing” OR “tracing contact*” OR “contact follow-up” OR “case detection*” OR “contact investigation*” OR “epidemic investigation*” with no language or date restrictions. MEDLINEsuggested: (MEDLINE, RRID:SCR_002185)Embasesuggested: (EMBASE, RRID:SCR_001650)To find additional articles, we also reviewed reference lists, used the “related articles” and “cited by” functions in Google Scholar and PubMed, searched our own files, and consulted with colleagues. Google Scholarsuggested: (Google Scholar, RRID:SCR_008878)PubMedsuggested: (PubMed, RRID:SCR_004846)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Tracing contacts manually over the telephone has a number of limitations. First, it is likely that not all contacts will be traced. Cases may not disclose, remember, or have contact information for all contacts. For example, a pilot programme in Sheffield, UK, found that two thirds of people contacted through tracing did not fully cooperate (Mahase, 2020). Second, during a peak of COVID-19, thousands of new contacts may need to be traced daily. This poses substantial operational challenges. Large contact tracing efforts with new staff are costly, and may not be able to maintain the level of effectiveness of smaller programmes with experienced staff. For example, UK’s test and trace programme cost ten billion pounds and may not have been effective (Iacobucci, 2020). Mobile phone apps and other technologies can circumvent these shortcomings, but raise a number of ethical issues (Bradford et al. 2020; Austin et al. 2020) and pose technological challenges (Ivers and Weitzner, 2020). Moreover, early evidence suggests that contact tracing apps, despite wide encouragement, have limited adoption (Sim and Lim, 2020; Johnson, 2020). Thus, they may only contribute to slowing (but not stopping) spread of COVID-19. Other key steps of the contact tracing process are isolations and quarantines. Ineffective isolations and quarantines may compromise otherwise flawless tracing efforts. Four of the five modelling studies we have reviewed assumed perfect prevention of transmission at these steps...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-